-- Announcement on Resignation of Director and Election of Employee Representative Director
Securities code: 603367 Securities abbreviation: Chenxin Pharmaceutical Announcement number: 2025-052
Chenxin Pharmaceutical Co., Ltd.
Announcement on the resignation of company directors and election of employee representative directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
The board of directors of Chenxin Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "Chenxin Pharmaceutical") received the resignation of director Mr. Xu Xinbing on September 23, 2025. Due to work adjustments, Mr. Xu Xinbing resigned as a director of the company and a member of the remuneration and assessment committee of the board of directors, and confirmed that there are no differences of opinion with the company's board of directors, and there are no matters that need to be brought to the attention of the company's shareholders and creditors. After Mr. Xu Xinbing resigned, he continued to hold other positions in the company and its holding subsidiaries. On September 23, 2025, the company held an employee representative meeting and resolved to elect Mr. Xu Xinbing as employee representative director.
1. Resignation status of directors/senior managers
(1) Basic circumstances of early resignation
Whether to continue
Does it exist on
Still unfulfilled
Original term Municipal Corporation
Name Resignation position Time of resignation Reason for resignation Specific position (if applicable) Expiry date of completion of service and its control
of public subsidiaries
Commitment
Secretary position
Continued new recruits Director, Director 2025.9.23 2027.2.28 Work adjustment Yes Secretary of the Board of Directors, Financial Director, Shandong Chenxin Whether the remuneration will be related to Director of Pharmacy Chain Co., Ltd., Jining Hong Assessment Committee Director of Qiao Technology Venture Capital Co., Ltd., Member of Shanhui Supervisor of Dongchenlong Pharmaceutical Co., Ltd.
(2) The impact of resignation on the company
Mr. Xu Xinbing's resignation will not cause the number of board members to fall below the quorum, nor will it affect the normal operation of the company's board of directors. Mr. Xu Xinbing has completed the work handover in accordance with the company's internal system. It will not have any adverse impact on the company's standardized operations and daily operations.
After Mr. Xu Xinbing resigned, he continued to serve in other positions in the company (employee representative director) and the company's holding subsidiaries.
2. Election of employee representative directors
In order to further improve the corporate governance structure, in accordance with the "Company Law of the People's Republic of China", "Guidelines on the Articles of Association of Listed Companies" and other laws, regulations and normative documents, as well as the relevant provisions of the "Articles of Association", the company's board of directors has an employee representative director, who is elected by the employee representative conference.
The company held an employee representative meeting on September 23, 2025. After deliberation and voting by all employee representatives present at the meeting, Mr. Xu Xinbing (resume attached) was elected as the employee representative director of the company's fifth board of directors. Mr. Xu Xinbing and the non-employee representative directors of the fifth board of directors elected by the company's shareholders' meeting jointly constitute the company's fifth board of directors. Their term starts from the date of election and approval by the company's employees' representative meeting and ends on the date when the term of the company's fifth board of directors expires. Mr. Xu Xinbing complies with the requirements for director qualifications and conditions set forth in the Company Law and other laws, regulations and normative documents. After he was elected as the employee representative director of the company, the number of directors who concurrently held senior management positions and were employee representatives in the company's fifth board of directors did not exceed one-half of the company's total directors, which complied with the requirements of relevant laws and regulations.
Announcement is hereby made.
Board of Directors of Chenxin Pharmaceutical Co., Ltd.
Resume attachment on September 23, 2025:
Continued recruit, male, Chinese nationality, no right of residence abroad, born in 1978, university degree, senior accountant. Graduated from Shandong University of Finance in 2000. From August 2000 to December 2012, he successively served as the accountant, director of the financial department, and director of the audit department of Chenxin Pharmaceutical Co., Ltd. From January 2013 to December 2017, he served as the director of the manager’s office of Chenxin Pharmaceutical Co., Ltd., and from December 2017 to present, he served as the director of the financial department of Chenxin Pharmaceutical Co., Ltd. He currently serves as employee representative director, board secretary and financial director of Chenxin Pharmaceutical Co., Ltd.
As of the disclosure date of this announcement, Mr. Xu Xinbing does not hold shares in the company, has not been punished by the China Securities Regulatory Commission, the Shanghai Stock Exchange and other relevant departments, and has no affiliation with the company’s directors, supervisors, senior managers, actual controllers and other shareholders holding more than 5% of the shares. His qualifications are in compliance with laws, administrative regulations, the relevant provisions of the China Securities Regulatory Commission and the Shanghai Stock Exchange.